Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY30.61 CNY
Change Today -0.10 / -0.33%
Volume 18.3M
002653 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Taiwan Strait Technology Industry Development Park

No. 136, Baili Road

Wenjiang District

Chengdu,

China

Phone: 86 89 3783 4865

Fax:

Xizang Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers capsules, tablets, granules, and bulk drugs in the fields of cardiovascular, anti-infection, digestive system, nervous and mental system, hepatopathy, diabetes mellitus, etc., as well as liver disease, parenteral nutrition, first-aid, antibiotics, anesthesia, and tumor adjuvant. It is also developing nalmefene hydrochloride injection, dolasetron mesylate injection, cefodizime sodium for injection, hydroxyethyl starch and sodium chloride injection, medium and long chain fat emulsion injection, and compound amino acids injection. The company was founded in 2000 and is based in Chengdu, China.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY30.61 CNY -0.10

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 71.5x
Price/Sales 27.6x
Price/Book 15.3x
Price/Cash Flow 70.6x
TEV/Sales 25.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit www.haisco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.